If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

Share Price is delayed by 15 minutes
Get Live Data
432.20    24.60 (6.04%)
Bid:
432.20
Ask:
433.80
Spread: 1.60 (0.37%)
Market Cap: £651.38m
CBG Live PriceLast checked at - London Stock Exchange

Intraday Close Bros Share Chart

Publication of a Prospectus

12 Jun 2023 16:24

RNS Number : 4450C
Close Brothers Group PLC
12 June 2023
 

12 June 2023

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR ITS TERRITORIES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS OR OTHERWISE THAN TO PERSONS TO WHOM IT CAN LAWFULLY BE DISTRIBUTED

CLOSE BROTHERS GROUP PLC

PUBLICATION OF PROSPECTUS

The following prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Prospectus dated 12 June 2023 (the "Prospectus") relating to the issue of £250,000,000 7.750 per cent. Notes due 14 June 2028 (the "Notes").

To view the full Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/4450C_1-2023-6-12.pdf

The Prospectus will also be available for viewing at the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

For further information, please contact:

Penny ThomasCompany SecretaryClose Brothers Group plcLEI code: 213800W73SYHR14I3X91 10 Crown PlaceLondon EC2A 4FT+44 (0)20 7655 3100

DISCLAIMER - INTENDED ADDRESSEES

EU MiFID II professionals/ECPs only/No EEA PRIIPs KID

UK MiFIR professionals/ECPs only/No UK PRIIPs KID

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (as specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, neither this announcement nor the Prospectus shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The Notes have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act"), or under the securities laws of any state or other jurisdiction of the United States, and the Notes may not be offered, sold, pledged, taken up, resold, transferred or delivered, directly or indirectly, in the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act ("Regulation S")) unless the Notes are registered under the Securities Act or an exemption from the registration requirements for the Securities Act is available. The Notes are being offered and sold only to non-U.S. persons outside the United States in reliance upon Regulation S. The Prospectus may not be accessed from, or transmitted in or into, the United States.

Your right to access this service is conditional upon complying with the above requirements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIZLLFFXQLLBBV
Date   Source Headline
1st Jul 20265:00 pmRNSTotal Voting Rights
1st Jul 20264:00 pmRNSOutcome of Audit Tender Process
8th Jun 20262:00 pmRNSDirector/PDMR Shareholding
1st Jun 20264:15 pmRNSTotal Voting Rights
21st May 20265:15 pmRNSDirector/PDMR Shareholding
21st May 20267:00 amRNSTrading Statement
13th May 20261:00 pmRNSRedemption of Subordinated Notes due 2031
6th May 20264:00 pmRNSDirector/PDMR Shareholding
1st May 20263:00 pmRNSTotal Voting Rights
29th Apr 202612:15 pmRNSDirector/PDMR Shareholding
23rd Apr 202611:45 amRNSHolding(s) in Company
15th Apr 20265:45 pmRNSHolding(s) in Company
14th Apr 20265:00 pmRNSDirector/PDMR Shareholding
9th Apr 20265:15 pmRNSDirector/PDMR Shareholding
8th Apr 20264:46 pmRNSDirector/PDMR Shareholding
8th Apr 20267:00 amRNSUpdate in relation to motor finance commissions
1st Apr 20264:15 pmRNSTotal Voting Rights
30th Mar 20265:08 pmRNSStatement in relation to motor finance commissions
17th Mar 20264:30 pmRNSTransaction in Own Shares
17th Mar 20267:00 amRNSHalf-year Report for six months to 31 January 2026
17th Mar 20267:00 amRNSHalf-year Report for six months to 31 January 2026
16th Mar 20265:40 pmRNSStatement regarding report from Viceroy Research
6th Mar 20264:45 pmRNSDirector/PDMR Shareholding
2nd Mar 20265:45 pmRNSTotal Voting Rights
23rd Feb 20264:45 pmRNSTransaction in Own Shares
16th Feb 20264:30 pmRNSTransaction in Own Shares
9th Feb 20265:45 pmRNSDirector/PDMR Shareholding
9th Feb 20265:30 pmRNSTransaction in Own Shares
3rd Feb 20269:40 amRNSResult of Tender Offer
2nd Feb 20265:25 pmRNSTransaction in Own Shares
2nd Feb 20265:10 pmRNSTotal Voting Rights
30th Jan 20263:00 pmRNSPublication of Admission Particulars
26th Jan 20265:00 pmRNSTransaction in Own Shares
26th Jan 20269:20 amRNSTender Offer
19th Jan 20265:30 pmRNSTransaction in Own Shares
12th Jan 20265:45 pmRNSDirector/PDMR Shareholding
12th Jan 20263:45 pmRNSTransaction in Own Shares
7th Jan 20265:45 pmRNSTransaction in Own Shares
6th Jan 20265:15 pmRNSDirector/PDMR Shareholding
5th Jan 20262:45 pmRNSTotal Voting Rights
29th Dec 20254:40 pmRNSDirector/PDMR Shareholding
29th Dec 20254:40 pmRNSDirector/PDMR Shareholding
22nd Dec 20253:30 pmRNSTransaction in Own Shares
22nd Dec 20253:30 pmRNSTransaction in Own Shares
15th Dec 20254:00 pmRNSHolding(s) in Company
15th Dec 202512:02 pmRNSTransaction in Own Shares
8th Dec 20255:15 pmRNSDirector/PDMR Shareholding
2nd Dec 20254:30 pmRNSTotal Voting Rights
1st Dec 20257:00 amRNSClose Brothers completes Winterflood sale to Marex
28th Nov 20254:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.